A New Indicator to Assess Stenosis Severity

Fractional Myocardial Mass to Assess Stenosis Severity

This study looked at the role of fractional myocardial mass (vessel-specific myocardial mass) in the assessment of stenosis physiological severity.

 

Researchers used CT angiography to study this new concept of myocardial mass subtended by a specific vessel, which could reduce anatomical-physiological mismatch.

 

The study included 463 patients with 724 lesions evaluated by multislice coronary computed tomography angiography and invasive coronary angiography with fractional flow reserve measurement (FFR).

 

Fractional myocardial mass was assessed based on arterial tree length and myocardial mass by CT.

 

FFR <0.80 was considered a functionally significant lesion and it was found in 39% of observed vessels. Fractional myocardial mass decreased consistently according to vessel caliber, which is obvious.

 

FFR <0.80 increased in direct proportion to fractional myocardial mass and inversely to angiographic minimal luminal diameter (p < 0.001).

 

Fractional myocardial mass and minimal luminal diameter showed good correlation with FFR (r=0.61) and resulted superior to stenosis diameter to predict FFR <0.80.

 

Optimal cutoff value for fractional myocardial mass/minimal luminal diameter was 29 g/mm with 75% sensitivity,   77% specificity and 77% diagnostic accuracy.

 

This relation could add information to the classical stenosis diameter to predict FFR<0.80.

 

 

Conclusion

The relation fractional myocardial mass / minimal luminal diameter could help discriminate functional compromise of vessels more accurately than anatomical stenosis. The concept of fractional myocardial mass could explain the discrepancy between anatomy and physiology.

 

Original Title: Physiological Severity of Coronary Artery Stenosis Depends on the Amount of Myocardial Mass Subtended by the Coronary Artery.

Reference: Hyung Yoon Kim et al. JACC Cardiovasc Interv. 2016 Aug 8;9(15):1548-60.

 

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...